Video

David W. Goodman, MD: ADHD Presentations at NEI

Author(s):

Dr. David Goodman will present 5 times during NEI about different ADHD issues and topics.

There are a number of new treatments and therapies coming on board for attention deficit/hyperactivity disorder (ADHD).

During the annual Neuroscience Education Institute Max! Virtual meeting, David Goodman, MD, FAPA, assistant professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine, will present 5 different times about ADHD and some new insights into the disorder.

Goodman explained some of the confusion in ADHD he will address during 1 of his presentations will be the hierarchy of ADHD treatments. Currently, there are at least 29 different ADHD treatments coming from multiple medication families, leading to some confusion among doctors over what the right treatment ultimately is.

Goodman will also look at what the options are for doctors should a patient not respond to the first option for ADHD treatment.

He will also take a deeper dive into dosing during the virtual conference, trying to come up with a best practices checklist clinicians can use to find the right dosing for a given patient.

In the final presentation, Goodman will look at the connection between autism and ADHD and what the common comorbidities could be.

Related Videos
John Kane, MD | Credit: Northwell Health
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.